author-photo

Jingchen Cao

Van Andel Institute

6

Papers

146

Citations

Citation Trend

Filter By

Papers (4) Sort By

Journal Conference Others

Enzalutamide-induced and PTH1R-mediated TGFBR2 degradation in osteoblasts confers resistance in prostate cancer bone metastases.

2022 Cancer Letters
Show All
- Source
- Cite
- Save
Citations (0)
Enzalutamide-induced PTH1R-mediated TGFBR2 decrease in osteoblasts contributes to resistance in bone-metastatic prostate cancer

2019 bioRxiv
Show All
- Source
- Cite
- Save
Citations (1)
Mechanisms and approaches for overcoming enzalutamide resistance in prostate cancer

2018 Frontiers in Oncology
Show All
- Source
- Cite
- Save
Citations (22)
Loss of Myeloid-Specific TGF-β Signaling Decreases CTHRC1 to Downregulate bFGF and the Development of H1993-Induced Osteolytic Bone Lesions.

2018 Cancers
Show All
- Source
- Cite
- Save
Citations (8)